Wu, Shun-Quan <br/><br/>
ShRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib.  [electronic resource] 

 -  International journal of molecular medicine  Aug 2014 
 - 616-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-244X 
<br/><br/><label>Standard No.: </label>10.3892/ijmm.2014.1798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>Mice<br/>Mitogen-Activated Protein Kinase 7--antagonists & inhibitors<br/>Multiple Myeloma--drug therapy<br/>Primary Cell Culture<br/>Pyrazines--administration & dosage